Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Vanderdonckt

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Neurovirology|November 4, 2021
Susac syndrome complicating a SARS-CoV-2 infectionVincent Raymaekers, Simon D'hulst, Dorien Herijgers, et al.
BMC Neurology|June 23, 2021
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experienceMarie D'hooghe, Barbara Willekens, Valerie Delvaux, et al.
Brain Communications|April 28, 2022
Tissue donations for multiple sclerosis research: current state and suggestions for improvementPatrick Vanderdonckt, Francesca Aloisi, Giancarlo Comi, et al.
Acta Neurologica Belgica|June 12, 2014
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational programVincent van Pesch, Emmanuel Bartholomé, Véronique Bissay, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Neurovirology|November 4, 2021
Susac syndrome complicating a SARS-CoV-2 infectionVincent Raymaekers, Simon D'hulst, Dorien Herijgers, et al.
BMC Neurology|June 23, 2021
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experienceMarie D'hooghe, Barbara Willekens, Valerie Delvaux, et al.
Brain Communications|April 28, 2022
Tissue donations for multiple sclerosis research: current state and suggestions for improvementPatrick Vanderdonckt, Francesca Aloisi, Giancarlo Comi, et al.
Acta Neurologica Belgica|June 12, 2014
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational programVincent van Pesch, Emmanuel Bartholomé, Véronique Bissay, et al.
Pageof 1